INTRODUCTION
T he majority of cases of congenital nephrotic syndrome have mutations in components of glomerular filtration barrier especially nephrin and podocin. Mutations in genes highly expressed in podocytes have been found in two-thirds of patients presenting with steroid-resistant nephrotic syndrome in the first year of life. [1] [2] [3] [4] Mutations in 7 genes (NPHS1, NPHS2, CD2AP, PLCE1, ACTN4, TRPC6, and INF2) are implicated in different forms of nonsyndromic steroid-resistant nephrotic syndrome. 2 We report a rare family with multiple cases of congenital nephrotic syndrome, with all of them progressing to end-stage renal disease during infancy.
CASE PRESENTATION
A 4-month-old boy presented at our clinic with acute gastroenteritis and anasarca, with the latter beginning at 2.5 months of age, and worsening progressively due to nephrotic range proteinuria. The child was born full term to an Indian family. He had a family history of anasarca that progressed to renal failure and death of 2 siblings at the age of 2 years and 9 months, respectively ( Figure 1 ). Both siblings had early onset at around 2 months of life with anasarca. Laboratory parameters are shown in Table 1 .
Kidney biopsy was done to underpin the etiology of his congenital nephrotic state. Light microscopy revealed 12 glomeruli, of which 8 were completely sclerosed with podocytic hyperplasia. Examination of the tubulointerstitial compartment showed patchy tubular atrophy, interstitial inflammation, and fibrosis involving 20%-25% of the cortex sampled. There was marked microcystic dilation of the tubules with occasional broad hyaline cast ( Figure 2 ). Immunofluorescence was negative for Igs and complement. Electron microscopy revealed diffuse podocyte foot process effacement with focal areas of podocytic detachment and glomerular basement membrane wrinkling. Mild mesangial matrix expansion was also noted.
The diagnosis of familial congenital nephrotic syndrome was considered in this patient because of a positive family history of renal failure with an autosomal recessive inheritance pattern and early onset of nephrotic syndrome. Mutation analysis by Sanger sequencing was done for NPHS1 (29 exons), WT1 (for exons 8 and 9), and PLCE1 (31 exons). We identified a novel homozygous nonsense mutation located in exon 7 (c.2290G>T, p.Glu764*) of the PLCE1 gene. This is consistent with the diagnosis of autosomal recessive steroid-resistant congenital nephrotic syndrome type 3 (NPHS3) (Figure 3 ). The affected child developed early onset disease and inherited the mutation from his asymptomatic parents who were both heterozygous carriers.
The child received oral indomethacin and oral enalapril till 9 months of life. His indomethacin was stopped when his serum creatinine started increasing. He progressed to chronic kidney disease-stage V at 1 year of life, and he succumbed to his illness at home.
DISCUSSION
NPHS3 is a severe form of isolated congenital nephrotic syndrome with rapid progression to terminal renal failure. It is caused by a developmental rather than structural podocyte dysfunction, as PLCE1 has been implicated in glomerulogenesis. It is a major cause of isolated diffuse mesangial sclerosis. Apart from NPHS2 and NPHS1, PLCE1 is involved in some cases of infantile and childhood-onset steroid-resistant nephrotic syndrome.
1-3 Causes of congenital nephrotic syndrome are summarized in Table 2 .
Mutations in PLCE1, WT1, and LAMB2 genes can cause isolated diffuse mesangial sclerosis, with PLCE1 being the most common cause. 3, 4 It is proposed that renal histopathologic patterns corroborate with the kidney developmental stages at which PLCE1 activity is required. Accordingly, diffuse mesangial sclerosis occurs from a developmental arrest due to truncating PLCE1 mutations, whereas focal segmental glomerulosclerosis arises from low-level or dysfunctional PLCE1 in the less severe molecular defects. [1] [2] [3] Therapy response in NPHS3 cases has been documented in a few cases, opening insights into genomic and nongenomic effects of glucocorticoids on podocytes. 2, 4 Positional cloning has uncovered mutations in PLCE1 responsible for nephrotic syndrome that may be reversible with immunosuppressants. 2 Most intriguing aspects with PLCE1 mutations are the genotype-phenotype variability and response to immunosuppressants that have been documented in various studies, reiterating the importance of performing mutation analysis for all implicated genes in congenital nephrotic syndrome. We however did not use any immunosuppression in the case, in view of rapid deterioration of renal function during infancy. This report further highlights the idea that both clinical course and histology in NPHS3 are subject to genotypic variability and that mutational analysis is the most reliable diagnostic tool. Future studies are needed to determine the clinical implications of NPHS3.
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